Sign in
4

Changes in Ownership

Alkermes plc. Filed Acc 0001127602-21-025401

EVP R&D, Chief Medical Officer gave up 5,647 shares (to pay taxes)

  • EVP R&D, Chief Medical Officer acquired 15,143 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2021-09-14 Grant or award +15,143 15,143 D: show line 1 in the form
Hopkinson Craig C. EVP R&D, Chief Medical Officer 2021-09-14 Shares withheld for taxes −5,647 $30.60 $172,798 9,496 D: show line 2 in the form
Loading xslF345X03/form4.xml…